Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Healthcare Regulatory Affairs Outsourcing Industry: Supply and Demand, Markets and Prices 2021-2027

Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Healthcare Regulatory Affairs Outsourcing Market Status and Forecast (2016-2027)
      • 1.3.2 Global Healthcare Regulatory Affairs Outsourcing Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Healthcare Regulatory Affairs Outsourcing Supply by Company

    • 2.1 Global Healthcare Regulatory Affairs Outsourcing Sales Value by Company
    • 2.2 Healthcare Regulatory Affairs Outsourcing Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Healthcare Regulatory Affairs Outsourcing Market Status by Category

    • 3.1 Healthcare Regulatory Affairs Outsourcing Category Introduction
      • 3.1.1 Regulatory Writing and Publishing
      • 3.1.2 Regulatory Submissions
      • 3.1.3 Clinical Trial Applications
      • 3.1.4 Product Registrations
      • 3.1.5 Regulatory Consulting and Legal Representation
      • 3.1.6 Others
    • 3.2 Global Healthcare Regulatory Affairs Outsourcing Market by Category
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Healthcare Regulatory Affairs Outsourcing Market Status by End User/Segment

    • 4.1 Healthcare Regulatory Affairs Outsourcing Segment by End User/Segment
      • 4.1.1 Mid-Size Pharmaceutical Companies
      • 4.1.2 Large Pharmaceutical Companies
      • 4.1.3 Biotechnology Companies
      • 4.1.4 Medical Devices Manufacturer
      • 4.1.5 Food & Beverage Companies
    • 4.2 Global Healthcare Regulatory Affairs Outsourcing Market by End User/Segment
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Healthcare Regulatory Affairs Outsourcing Market Status by Region

    • 5.1 Global Healthcare Regulatory Affairs Outsourcing Market by Region
    • 5.2 North America Healthcare Regulatory Affairs Outsourcing Market Status
    • 5.3 Europe Healthcare Regulatory Affairs Outsourcing Market Status
    • 5.4 Asia Pacific Healthcare Regulatory Affairs Outsourcing Market Status
    • 5.5 Central & South America Healthcare Regulatory Affairs Outsourcing Market Status
    • 5.6 Middle East & Africa Healthcare Regulatory Affairs Outsourcing Market Status

    6 North America Healthcare Regulatory Affairs Outsourcing Market Status

    • 6.1 North America Healthcare Regulatory Affairs Outsourcing Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Healthcare Regulatory Affairs Outsourcing Market Status

    • 7.1 Europe Healthcare Regulatory Affairs Outsourcing Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Healthcare Regulatory Affairs Outsourcing Market Status

    • 8.1 Asia Pacific Healthcare Regulatory Affairs Outsourcing Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Healthcare Regulatory Affairs Outsourcing Market Status

    • 9.1 Central & South America Healthcare Regulatory Affairs Outsourcing Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Healthcare Regulatory Affairs Outsourcing Market Status

    • 10.1 Middle East & Africa Healthcare Regulatory Affairs Outsourcing Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Healthcare Regulatory Affairs Outsourcing Market Forecast by Category and by End User/Segment

    • 12.1 Global Healthcare Regulatory Affairs Outsourcing Sales Value Forecast (2022-2027)
    • 12.2 Global Healthcare Regulatory Affairs Outsourcing Forecast by Category
    • 12.3 Global Healthcare Regulatory Affairs Outsourcing Forecast by End User/Segment

    13 Global Healthcare Regulatory Affairs Outsourcing Market Forecast by Region/Country

    • 13.1 Global Healthcare Regulatory Affairs Outsourcing Market Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 PAREXEL
      • 14.1.1 Company Information
      • 14.1.2 Healthcare Regulatory Affairs Outsourcing Product Introduction
      • 14.1.3 PAREXEL Healthcare Regulatory Affairs Outsourcing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Weinberg
      • 14.2.1 Company Information
      • 14.2.2 Healthcare Regulatory Affairs Outsourcing Product Introduction
      • 14.2.3 Weinberg Healthcare Regulatory Affairs Outsourcing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Quintiles IMS
      • 14.3.1 Company Information
      • 14.3.2 Healthcare Regulatory Affairs Outsourcing Product Introduction
      • 14.3.3 Quintiles IMS Healthcare Regulatory Affairs Outsourcing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Pharmaceutical Product Development
      • 14.4.1 Company Information
      • 14.4.2 Healthcare Regulatory Affairs Outsourcing Product Introduction
      • 14.4.3 Pharmaceutical Product Development Healthcare Regulatory Affairs Outsourcing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 ICON
      • 14.5.1 Company Information
      • 14.5.2 Healthcare Regulatory Affairs Outsourcing Product Introduction
      • 14.5.3 ICON Healthcare Regulatory Affairs Outsourcing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Freyr Solutions
      • 14.6.1 Company Information
      • 14.6.2 Healthcare Regulatory Affairs Outsourcing Product Introduction
      • 14.6.3 Freyr Solutions Healthcare Regulatory Affairs Outsourcing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Covance
      • 14.7.1 Company Information
      • 14.7.2 Healthcare Regulatory Affairs Outsourcing Product Introduction
      • 14.7.3 Covance Healthcare Regulatory Affairs Outsourcing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Clinilabs
      • 14.8.1 Company Information
      • 14.8.2 Healthcare Regulatory Affairs Outsourcing Product Introduction
      • 14.8.3 Clinilabs Healthcare Regulatory Affairs Outsourcing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Accell
      • 14.9.1 Company Information
      • 14.9.2 Healthcare Regulatory Affairs Outsourcing Product Introduction
      • 14.9.3 Accell Healthcare Regulatory Affairs Outsourcing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.9.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Healthcare Regulatory Affairs Outsourcing market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Healthcare Regulatory Affairs Outsourcing market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Regulatory Writing and Publishing
      Regulatory Submissions
      Clinical Trial Applications
      Product Registrations
      Regulatory Consulting and Legal Representation
      Others

      Segmented by End User/Segment
      Mid-Size Pharmaceutical Companies
      Large Pharmaceutical Companies
      Biotechnology Companies
      Medical Devices Manufacturer
      Food & Beverage Companies

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      PAREXEL
      Weinberg
      Quintiles IMS
      Pharmaceutical Product Development
      ICON
      Freyr Solutions
      Covance
      Clinilabs
      Accell

      Buy now